A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301) - Journal
Survival at one year in patients with lung cancer in a tertiary care center | International Journal of Medical Research and Review
Cutting-edge Medical Treatment for Advanced Non-small Cell Lung Cancer
Immunotherapy Improves Five-year Survival Rate of People with Advanced Lung Cancer - U Magazine - UCLA Health - Los Angeles, CA
α Syn Phospho (Abcam) | Bioz | Ratings For Life-Science Research
PDF) role of chemotherapy in PS3 Small cell lung cancer
Early mortality in lung cancer: French prospective multicentre observational study – topic of research paper in Health sciences. Download scholarly article PDF and read for free on CyberLeninka open science hub.
The Role of Performance Status in Small-Cell Lung Cancer in the Era of Immune Checkpoint Inhibitors - Clinical Lung Cancer
Real-World Treatment of Stage III NSCLC: The Role of Trimodality Treatment in the Era of Immunotherapy - Journal of Thoracic Oncology
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019) | SpringerLink
Stage 3 Lung Cancer: Survival Rate, Prognosis, and More
Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status - Adachi - 2020 - Cancer Medicine - Wiley Online Library
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR) - ESMO Open
Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival - ScienceDirect
Kaplan-Meier estimation of overall survival rate in patients with brain... | Download Scientific Diagram
Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival - ScienceDirect
Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab | Scientific Reports
Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry
Median survival for metastatic ALK+ lung cancer can be more than SIX YEARS! | Gray Connections
Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice | Anticancer Research
Epidemiology of lung cancer - ppt download
Distribution of cases in lung cancer, 5-year survival rate of lung... | Download Scientific Diagram
